In animal studies, 5-Amino-1MQ has been observed to reduce diet-induced fat mass in animal studies, preserve lean tissue, and improve overall metabolic resilience
Delivery time averages 2-3 weeks
Patients often report reduced hunger, smaller meal sizes, fewer cravings, and lower overall caloric intake
Always talk to your doctor if you notice any changes
The evidence reality There is no robust, high-quality human outcomes literature showing that adding AOD-9604 to semaglutide or tirzepatide produces clinically meaningful additional fat loss beyond what GLP-1/GIP therapy already achieves
Record the estimated dose injected (in micrograms), the time of injection, the reconstitution volume used, and the lot number on the vial